🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

18 recruiting trials

for Overweight or Obese Participants Without Diabetes

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes NCT07685808Phase 221 sites📍 Mobile📍 Walnut Creek📍 Waterbury Regeneron Pharmaceuticals · Tests: Olatorepatide, Placebo A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes NCT07670416Phase 321 sites📍 Zhengzhou📍 Xianyang📍 Ningbo Hoffmann-La Roche · Tests: Enicepatide, Placebo A Study to Evaluate Efficacy and Safety of BGM0504 Tablets in Overweight or Obese Participants Without Diabetes NCT07658560Phase 21 site📍 Beijing BrightGene Bio-Medical Technology Co., Ltd. · Tests: BGM0504 tablets, BGM0504 tablets, BGM0504 tablets, BGM0504 tablets, BGM0504 placebo A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide Medication NCT07868354Phase 12 sites📍 Glendale📍 Baltimore Novo Nordisk A/S · Tests: Tirzepatide, Zenagamtide Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1) NCT07481747Phase 31 site📍 Shenzhen Hudson Biotech · Tests: Tirzepatide, Placebo, Reduced-calorie diet A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes NCT07351045Phase 3209 sites📍 Anniston📍 Birmingham📍 Birmingham Hoffmann-La Roche · Tests: Placebo, Enicepatide Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity NCT07594093Phase 11 site📍 Glendale Regeneron Pharmaceuticals · Tests: REGN20934, Placebo A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM NCT07667803Phase 3325 sites📍 Birmingham📍 Dothan📍 Chandler AstraZeneca · Tests: Elecoglipron, Placebo A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus NCT07784725Phase 3220 sites📍 Dothan📍 Huntsville📍 Mesa AstraZeneca · Tests: Lenbelintide, Placebo A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus NCT07775404Phase 349 sites📍 Baotou📍 Beijing📍 Beijing AstraZeneca · Tests: Elecoglipron, Placebo A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin NCT07392190Phase 3185 sites📍 Birmingham📍 Phoenix📍 Scottsdale Eli Lilly and Company · Tests: Eloralintide, Placebo A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes NCT07321886Phase 3158 sites📍 Tuscaloosa📍 Scottsdale📍 Escondido Eli Lilly and Company · Tests: Eloralintide, Placebo Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without Diabetes NCT07279194Phase 31 site📍 Shanghai Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · Tests: HDM1005 1, HDM1005 2, Placebo A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes NCT06924320Phase 1, Phase 21 site📍 Cypress Pfizer · Tests: MET233 and MET097, Placebo, MET097 A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight NCT07589608Phase 240 sites📍 Chandler📍 Scottsdale📍 Tucson Eli Lilly and Company · Tests: Macupatide, Eloralintide, Placebo A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus NCT07776509Phase 396 sites📍 Escondido📍 Lincoln📍 Walnut Creek AstraZeneca · Tests: Lenbelintide, Placebo A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Semaglutide Medication NCT07855133Phase 12 sites📍 Glendale📍 Baltimore Novo Nordisk A/S · Tests: Semaglutide, Zenagamtide A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight NCT07564414Phase 3303 sites📍 Birmingham📍 Pelham📍 Gilbert Novo Nordisk A/S · Tests: Cagrisema, Semaglutide
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy